The Preferred Biotech Resource in Asia-Pacific
Vol 19, No 07, July 2015
Biotech in China
Kh-biotech cover


Eye on China


Conferences ListingConferences

Pharma Sales
iSonea launches new Asthmasense™ cloud technology
Medical technology company iSonea Ltd launched its latest smartphone asthma management application, AsthmaSense™ Cloud, to help medical experts track patient asthma data.

The product enables transfer and storage of asthma tracking data from the AsthmaSense smartphone app to a cloud based site where it is accessible to physicians and other caregivers.

CEO Mr. Mike Thomas said the company regarded the launch of AsthmaSense Cloud as another key milestone as it prepares to launch the AirSonea™ device in Australia later this year. This device will enable wheeze rate monitoring via smartphone for the first time, using iSonea’s proprietary Acoustic Respiratory Monitoring (ARM™) technologies.

“We are committed to continually upgrading our existing technologies to ensure we remain at the forefront of digital mobile health,” Mr. Thomas said.

“Launching this latest app advance is another key step forward as we progress toward commercializing the sophisticated AirSonea platform.”

The AsthmaSense Cloud app for iPhone and Android platforms includes enhanced features to track and manage chronic asthma. Features include:

  • Safe storage of a user’s asthma profile and event history in a password-protected, HIPAAcompliant, cloud-based data warehouse;
  • Protected access and easy data recovery if one’s phone is replaced, lost, stolen or damaged;
  • Ability to view or edit app data via computer;
  • Tracking system to identify potential risk patterns and trends in symptoms, medication use and testing results;
  • Interactive medication and testing reminders and medication usage records;
  • One-touch dialing of contact numbers, including auto-selected emergency number based on GPS location;
  • Ability to maintain multiple patient profiles with a single app - a benefit to families with more than one person suffering from asthma.

Mr Thomas added: “Growing asthma trends represent a serious challenge in Australia and globally. There is strong demand for better consumer-oriented asthma management tools. We are committed to improving patient outcomes at reduced costs. The Cloud technology is another new technology tool to help patients and their caregivers – including doctors – keep track of their conditions."

“By improving awareness of symptoms, events, medication usage, and potential risks, AsthmaSense Cloud can help people adhere to their asthma treatment plans.”

It is estimated there are 300 million asthma sufferers globally, with 25 million adults and children affected in the US and nearly 2.5 million affected in Australia.

The AsthmaSense smartphone app provides patients and caregivers with an easy-to-use monitoring tool that sends alerts and reminders to help manage the condition in accordance with a physician prescribed treatment plan. The addition of a convenient cloud portal increases the flexibility of storing, sharing, and editing the data.

Click here for the complete issue.